Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral agents for erectile dysfunction.

J S Kalsi1, S Minhas, P D Kell

  • 1Institute of Urology and Nephrology, University College, London.

Hospital Medicine (London, England : 1998)
|June 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of penoscrotal hidradenitis: a narrative review.

International journal of impotence research·2025
Same author

Commentary: Bioengineered dermal matrix reduces donor site morbidity in total phallic construction with RAFFF.

International journal of impotence research·2024
Same author

Surgical and minimally invasive treatment of ischaemic and non-ischaemic priapism: a systematic review by the EAU Sexual and Reproductive Health Guidelines panel.

International journal of impotence research·2022
Same author

What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel.

International journal of impotence research·2022
Same author

Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis.

Journal of endocrinological investigation·2022
Same author

Management of Disastrous Complications of Penile Implant Surgery.

The journal of sexual medicine·2021
Same journal

Management of non-thrombolysable acute coronary syndrome (ACS).

Hospital medicine (London, England : 1998)·2005
Same journal

Case report: treatment of faecaloma of the colon.

Hospital medicine (London, England : 1998)·2005
Same journal

Should anaesthetists scrub? The case for and against.

Hospital medicine (London, England : 1998)·2005
Same journal

Angiosarcoma: a difficult diagnosis.

Hospital medicine (London, England : 1998)·2005
Same journal

Pitfalls in recurrent varicose vein surgery.

Hospital medicine (London, England : 1998)·2005
Same journal

Aorto-caval fistula.

Hospital medicine (London, England : 1998)·2005
See all related articles

Erectile dysfunction (ED) affects millions globally. This review covers currently available oral ED treatments, including the first medication, sildenafil, and newer options.

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) is a prevalent condition impacting men's quality of life worldwide.
  • Sildenafil was the pioneering oral therapeutic agent approved for treating male ED.
  • Numerous alternative oral treatments for ED have since become available.

Purpose of the Study:

  • To provide a comprehensive review of the oral medications currently available for erectile dysfunction.
  • To summarize the efficacy and safety profiles of existing oral ED therapies.

Main Methods:

  • Literature review of published studies on oral erectile dysfunction treatments.
  • Analysis of clinical trial data and pharmacological information for available medications.

Main Results:

Related Experiment Videos

  • Sildenafil remains a key treatment option for erectile dysfunction.
  • Several other oral medications with varying mechanisms of action and efficacy are now available.
  • The review details the characteristics of these diverse therapeutic options.

    • Conclusions:

    • A range of effective oral treatments for erectile dysfunction are accessible to patients.
    • Treatment selection should be individualized based on patient factors and medication profiles.
    • Ongoing research continues to expand therapeutic options for ED.